CBC oils, like many other minorly recognized cannabinoids, are gaining momentum in the cannabinoid market. At present, CBC oils' interest is rather unfounded and lacks quite a bit of substance when it comes to all the curiosity it sparks.
Not because CBC oils are of unreputable sources or the benefits they provide are untruthful. But because the whole atmosphere in the cannabis industry screams 'constant innovation.' So, it's only natural to feel confused and, at times, distrustful of new product launches.
But we're here to tell you the truth about CBC Oil. How it works, where it comes from, and why it's gaining popularity. More importantly, what it may or may not do for you.
What Is CBC Oil?
The name ‘CBC oil’ comes from the primary component found in the finished good. Cannabichromene (CBC) is one of the 113+ cannabinoids found to date in the cannabis plant.
Unlike CBD and THC (the compound’s more famous cousins), CBC is considered a phytocannabinoid, which is just a fancy word to describe a naturally occurring cannabinoid. In other words, CBC is created in the plant after a series of natural internal processes.
Just like CBD, CBC oils are non-psychoactive. Meaning, CBC does not make you feel ‘high’ when consumed on its own. -ñ8-ñ8z
THC, on the other hand, is the only psychoactive cannabinoid found in cannabis. So, as long as you steer clear of THC, you should be alright. Remember, THC in negligent quantities (0.3% per unit of dry weight) is bound to have no evident effect on the body.
CBC oils come from natural extracts, usually from the hemp plant, which then turn into fats by mixing them with carrier substances. Carrier oils often include coconut, MCT, and hemp seed oil.
CBC oils can be applied directly on the skin or under the tongue as a sublingual product. Each application method may provide different results and benefits.
Is CBC Oil for Vape a Thing?
CBC oils for vape products are slowly hopping onto the scene on top of sublingual and topical applications.
Because CBC oils are so new to the cannabis market, it’s not very often you’ll encounter CBC oil for vape devices. Even online, it might be hard to find something you feel comfortable with.
That’s where a brand like Hemmfy.com comes in. If you can’t find a non-psychoactive cannabis-derived product that you want to try, a licensed online retailer like Hemmfy is probably your best bet.
CBC oil for vape purposes poses an essential advantage over other applications; a faster onset. Because vaping a substance means it will be absorbed directly through the lungs’ glands, it allows CBC to reach the bloodstream faster than it would any other way.
With CBC oil for vape, you can also target various purposes than you would with a topical or sublingual application.
Are There Any CBC Benefits?
To understand any potential CBC benefits, we first need to know how CBC oils act on the body.
The reason why CBC and other compounds don’t have a psychoactive effect on the brain as would THC is in part due to the low binding prowess of the combination on CB1 receptors.
CBC molecules are quite adept at binding to other receptors.
By binding to these receptors, CBC triggers the release of naturally released substances in the body like Anandamide, an essential omega-6 fatty acid, a substance that plays a role in the neural generation of motivation and pleasure.
As with THC and CBD, CBC is suspected of interacting positively with other cannabinoids, terpenes, and flavonoids. These are other cannabis-derived compounds that could enhance the effects of CBC or whose effects could be improved by consuming them in parallel with CBC oils.
This behavior is known as ‘the entourage effect.’
However, the entourage effect is not a clinically proven phenomenon, rather than an anecdotally created subject. Based on particular user’s personal experiences and observations.
While CBC benefits have been linked to various symptoms, perhaps the most important to mention is the potential use of CBC oil for pain.
A 2011 study found that “CBD and CBC stimulated descending pathways of antinociception and caused analgesia by interacting with several target proteins involved in nociceptive control”.
In other words, CBC blocks sensors in the nervous system from detecting pain.
The real potential of CBC oil for pain and other symptoms is yet to be clinically determined. Using CBC oils or any cannabis-derived products for medicinal purposes should first be consulted with a licensed physician to assess your medical condition.
Difference Between CBC and CBG Oil
CBC and CBG oil are often taken together, and in some cases, confused. This confusion has to do with two things; the novelty of both products and the curiously similar effects on the body.
While they’re different compounds, CBC and CBG oil are both made from cannabis-derived extracts, and the potential uses for both are very similar.
The potential effects of most cannabinoid extracts are often marketed similarly. Typical uses of CBC and other cannabinoids include anxiety control and better sleep.
It’s also not uncommon to use both products together, looking to take advantage of the potential entourage effect. But CBC and CBG oil are two various products meant to deliver similar results with slightly different approaches.
CBC oils are products made with Cannabichromene (CBC), a particularly novel cannabinoid. They use a carrier oil as a base and are subsequently dosed with a proper amount of CBC.
CBC is non-psychoactive and has been found to prompt various body reactions, including potential pain and inflammation relief. CBC oils can be used in multiple formats, including topicals, sublingual drops, and vape juices or additives.
 Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., & Di Marzo, V. (2011). Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. British Journal of Pharmacology, 162(3), 584–596. https://doi.org/10.1111/j.1476-5381.2010.01063.x
 Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., & Di Marzo, V. (2011b). Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action. British Journal of Pharmacology, 162(3), 584–596. https://doi.org/10.1111/j.1476-5381.2010.01063.x
 DeLong, G. T., Wolf, C. E., Poklis, A., & Lichtman, A. H. (2010). Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ9-tetrahydrocannabinol☆. Drug and Alcohol Dependence, 112(1–2), 126–133. https://doi.org/10.1016/j.drugalcdep.2010.05.019
 Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. https://doi.org/10.1111/j.1476-5381.2011.01238.x